πŸ‡ΊπŸ‡Έ FDA
Patent

US 9682069

Methods of treating Dravet syndrome

granted A61KA61K31/437A61K45/06

Quick answer

US patent 9682069 (Methods of treating Dravet syndrome) held by OVID THERAPEUTICS INC. expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OVID THERAPEUTICS INC.
Grant date
Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/437, A61K45/06, A61K9/0053